BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. VEGFA, Fatty acid metabolic process, Obesity, Breast, Avian flu virus, Rapamycin)
Bookmark Forward

QuickView for Imatinib (compound)


Genetic Markers

Most Correlated Genes

  1. EGR1
  2. CYP1A1
  3. FOS
  4. FAM111A
  5. DUSP6
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. heterocyclic compound binding
  2. organic cyclic compound binding
  3. heterocycle metabolic process
  4. organic cyclic compound metabolic process
  5. cellular aromatic compound metabolic process
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Drug Matrix In Vivo Toxicogenomic Study - Rat Spleen [Codelink]
  2. Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Affymetrix]
  3. Gleevec treatment of BCR-ABL positive and negative leukemia cell lines
  4. Imatinib response in spleenocytes
  5. Hematopoietic stem cells expressing the TEL-PDGFRb gene fusion with and without imatinib treatment
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Deregulation of whole-transcriptome gene expression in zebrafish (Danio rerio) after chronic exposur…
  2. Long induction of tolerance to imatinib.
  3. Discontinuation of Imatinib in a Child With Chronic Myeloid Leukemia.
  4. A Case of Gastrointestinal Stromal Tumor of the Lower Rectum That Enabled Minimally Invasive Surgery…
  5. Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- a…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Drug-drug Interaction Study With Metformin and Imatinib
  2. Pulmonary Hypertension and Imatinib
  3. Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stro…
  4. Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
  5. Imatinib in KIT-negative Systemic Mastocytosis
Explore Clinical Trials Results
  • Copyright © 2021 Illumina Inc. All rights reserved.